A Non-interventional, Prospective, Observational Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 May 2018
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms APRAISAL
- Sponsors Genesis Pharma
- 11 May 2018 Planned End Date changed from 1 Apr 2019 to 10 Apr 2019.
- 11 May 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Apr 2017 Planned End Date changed from 1 Mar 2019 to 1 Apr 2019.